RSSMicro.com Search - RSS Feed Search Engine - RSS Feed Directory
Dedicated RSS Feed Search Engine
 Search 4.3 million RSS feeds
The most comprehensive RSS feed search on the web
Top Stories  |  FeedRank Checker

Published

   Last Hour

   Last Day

   Past Week

   Past Month

 Anytime







Featured
RSS Feeds


CNN RSS Feeds

Reuters RSS Feeds

MSNBC RSS Feeds

New York Times RSS Feeds

Washington Post RSS Feeds

CNBC RSS Feeds

ABC News RSS Feeds

Fox News RSS Feeds

Sky News RSS Feeds

Forbes RSS Feeds

CNET RSS Feeds

Unicef RSS Feeds

PBS RSS Feeds

Wall Street Journal RSS Feeds

Financial Times RSS Feeds

Business Week RSS Feeds

Bloomberg RSS Feeds

TheStreet RSS Feeds

ESPN RSS Feeds

   




FeedRank - RSSMicro Search

FeedRank, a newly developed algorithm for ranking RSS feeds only on RSSMicro
Click here to learn more


BloggingStocks


FeedRank: 5/10  5/10  Good  ---  bby.bloggingstocks.com
BloggingStocks ...

 

 
Wednesday, July 30, 2008 --- 112 days ago
Filed under: Analyst upgrades and downgrades , Best Buy (BBY) , Kimberly-Clark (KMB) , Amgen Inc (AMGN) , Analyst initiations Analyst upgrades Rodman & Renshaw upgraded shares of Amgen (NASDAQ: AMGN ) to Outperform from Market Perform following the positive top line results from the FREEDOM study. The firm established an $80 target. Jefferies upgraded shares to Buy from Hold following the positive top-line efficacy and safety results for Denosumab in PMO as they view it as a "big win." The firm raised their target to $71 from $47. Best Buy (NYSE: BBY ) was upgraded to Buy from Neutral at Banc of America. Goldman upgraded Kimberly Clark (NYSE: KMB ) to Neutral from Sell and Dick's Sporting Good (NYSE: DKS ) to Buy from Neutral. Rowan Companies (NYSE: RDC ) was lifted at JP Morgan to Neutral from Underweight. Analyst downgrades: Jesup & Lamont downgraded shares of Moog (NYSE: MOG.A ) to Neutral from Buy on concerns of the company's high rate of R&D and its relative valuation. Keefe Bruyette downgraded shares of Federated Investors to Market Perform from Outperform following the company's lower than expected Q2 results and cut their target to $35. Ryanair (NASDAQ: RYAAY ) was cut to Hold from Buy at Citigroup. Analyst initiations: Morgan Joseph believes Amgen (NASDAQ: AMGN )'s positive FREEDOM trial results will have a profound and lasting impact on the company's growth but also on its scientific credibility. The firm initiated cover ...




Recent Posts





 Facebook     Del.icio.us     Digg     StumbleUpon     Reddit     Google
Copyright © 2008 RSSMicro.com